Browsing Tag
Enfortumab
1 post
Enfortumab Vedotin Promising in Neovadjuvant Therapy in Advanced Bladder Cancer
Enfortumab vedotin () appeared to be effective as a neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) who were ineligible for cisplatin-based chemotherapy, according to a small phase Ib/II study. Results from a preliminary analysis of 22 patients showed that eight had a pathologic complete response (pCR, 36.4%, 95% CI 17.2-59.3), displaying no signs…